FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Alkermes Vivitrol Recall

Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial

Alkermes, Inc. · Waltham, MA

Risk level
Class II
Reported by FDA
Oct 9, 2019
Recall ID
D-0119-2020
Check your lot numberHow we source this data

Summary

Alkermes recalled Vivitrol starting Sep 26, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0119-2020 on Oct 9, 2019. Reason: Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.

Product description

Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01

Lot numbers, UPCs & expiration codes

Lot 2019-1002T, 2019-1003T, Exp 05/2021

Where it was sold

Nationwide USA and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0119-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 26, 2019
FDA report date
Oct 9, 2019
Quantity
16,231 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Alkermes, Inc.

Original FDA data

Every field from FDA enforcement report D-0119-2020, exactly as published.

Show all FDA fields
City
Waltham
State
MA
Status
Terminated
Country
United States
Event ID
83878
Address
852 Winter St
Code information
Lot 2019-1002T, 2019-1003T, Exp 05/2021
Postal code
02451-1420
Report date
Oct 9, 2019
Product type
Drugs
Recall number
D-0119-2020
Classification
Class II
Recalling firm
Alkermes, Inc.
Product quantity
16,231 kits
Termination date
Feb 19, 2021
Reason for recall
Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01
Distribution pattern
Nationwide USA and Canada
Recall initiation date
Sep 26, 2019
Initial firm notification
Letter
Center classification date
Oct 2, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0119-2020, published Oct 9, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls